Aptus Pharma Ltd vs Coral Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Aptus Pharma Ltd is ₹ 438 as of 06 May 15:30 . The P/E Ratio of Aptus Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Coral Laboratories Ltd changed from 8.5 on March 2021 to 10.4 on March 2025 . This represents a CAGR of 4.12% over 5 years The Market Cap of Aptus Pharma Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Coral Laboratories Ltd changed from ₹ 115.04 crore on March 2021 to ₹ 250.4 crore on March 2025 . This represents a CAGR of 16.83% over 5 years The revenue of Aptus Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Coral Laboratories Ltd for the Dec '25 is ₹ 24.06 crore as compare to the Sep '25 revenue of ₹ 22.07 crore. This represent the growth of 9.02% The ebitda of Aptus Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Coral Laboratories Ltd for the Dec '25 is ₹ 4.38 crore as compare to the Sep '25 ebitda of ₹ 7.97 crore. This represent the decline of -45.04% The net profit of Aptus Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Coral Laboratories Ltd changed from ₹ 8.8 crore to ₹ 2.78 crore over 7 quarters. This represents a CAGR of -48.24% The Dividend Payout of Aptus Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Coral Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aptus Pharma Ltd

Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010.
Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre. Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements.
It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products.

About Coral Laboratories Ltd

Coral Laboratories Limited (CLL) was established in February, 1997.
It was promoted by Navin B Doshi of the DWD Group.
To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company came up with a public issue in March, 1994 by raising funds of Rs.2.5 Crore.
It setup an additional ultra-modern manufacturing unit at Daman and the said Unit started the commercial production during March 2004.
It started the commercial production at Dehradun Plant in September, 2006. Presently, Company is into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines.

FAQs for the comparison of Aptus Pharma Ltd and Coral Laboratories Ltd

Which company has a larger market capitalization, Aptus Pharma Ltd or Coral Laboratories Ltd?

Market cap of Aptus Pharma Ltd is 300 Cr while Market cap of Coral Laboratories Ltd is 150 Cr

What are the key factors driving the stock performance of Aptus Pharma Ltd and Coral Laboratories Ltd?

The stock performance of Aptus Pharma Ltd and Coral Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aptus Pharma Ltd and Coral Laboratories Ltd?

As of May 6, 2026, the Aptus Pharma Ltd stock price is INR ₹438.0. On the other hand, Coral Laboratories Ltd stock price is INR ₹420.2.

How do dividend payouts of Aptus Pharma Ltd and Coral Laboratories Ltd compare?

To compare the dividend payouts of Aptus Pharma Ltd and Coral Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.